Copyright Reports & Markets. All rights reserved.

Global Biobanking LIMS Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biobanking LIMS Software by Type
    • 1.3.1 Overview: Global Biobanking LIMS Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biobanking LIMS Software Consumption Value Market Share by Type in 2025
    • 1.3.3 Cloud Based
    • 1.3.4 On-Premise
  • 1.4 Global Biobanking LIMS Software Market by Application
    • 1.4.1 Overview: Global Biobanking LIMS Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Regenerative Medicine
    • 1.4.3 Life Science
    • 1.4.4 Clinical Research
  • 1.5 Global Biobanking LIMS Software Market Size & Forecast
  • 1.6 Global Biobanking LIMS Software Market Size and Forecast by Region
    • 1.6.1 Global Biobanking LIMS Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Biobanking LIMS Software Market Size by Region, (2021-2032)
    • 1.6.3 North America Biobanking LIMS Software Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Biobanking LIMS Software Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Biobanking LIMS Software Market Size and Prospect (2021-2032)
    • 1.6.6 South America Biobanking LIMS Software Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Biobanking LIMS Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Cell&Co BioServices
    • 2.1.1 Cell&Co BioServices Details
    • 2.1.2 Cell&Co BioServices Major Business
    • 2.1.3 Cell&Co BioServices Biobanking LIMS Software Product and Solutions
    • 2.1.4 Cell&Co BioServices Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cell&Co BioServices Recent Developments and Future Plans
  • 2.2 RUCDR LIMS
    • 2.2.1 RUCDR LIMS Details
    • 2.2.2 RUCDR LIMS Major Business
    • 2.2.3 RUCDR LIMS Biobanking LIMS Software Product and Solutions
    • 2.2.4 RUCDR LIMS Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 RUCDR LIMS Recent Developments and Future Plans
  • 2.3 Csols
    • 2.3.1 Csols Details
    • 2.3.2 Csols Major Business
    • 2.3.3 Csols Biobanking LIMS Software Product and Solutions
    • 2.3.4 Csols Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Csols Recent Developments and Future Plans
  • 2.4 Agilent Technologies
    • 2.4.1 Agilent Technologies Details
    • 2.4.2 Agilent Technologies Major Business
    • 2.4.3 Agilent Technologies Biobanking LIMS Software Product and Solutions
    • 2.4.4 Agilent Technologies Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Agilent Technologies Recent Developments and Future Plans
  • 2.5 CloudLIMS
    • 2.5.1 CloudLIMS Details
    • 2.5.2 CloudLIMS Major Business
    • 2.5.3 CloudLIMS Biobanking LIMS Software Product and Solutions
    • 2.5.4 CloudLIMS Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CloudLIMS Recent Developments and Future Plans
  • 2.6 LabCollector
    • 2.6.1 LabCollector Details
    • 2.6.2 LabCollector Major Business
    • 2.6.3 LabCollector Biobanking LIMS Software Product and Solutions
    • 2.6.4 LabCollector Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 LabCollector Recent Developments and Future Plans
  • 2.7 OpenSpecimen
    • 2.7.1 OpenSpecimen Details
    • 2.7.2 OpenSpecimen Major Business
    • 2.7.3 OpenSpecimen Biobanking LIMS Software Product and Solutions
    • 2.7.4 OpenSpecimen Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 OpenSpecimen Recent Developments and Future Plans
  • 2.8 BSI Systems
    • 2.8.1 BSI Systems Details
    • 2.8.2 BSI Systems Major Business
    • 2.8.3 BSI Systems Biobanking LIMS Software Product and Solutions
    • 2.8.4 BSI Systems Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BSI Systems Recent Developments and Future Plans
  • 2.9 TDBioBank
    • 2.9.1 TDBioBank Details
    • 2.9.2 TDBioBank Major Business
    • 2.9.3 TDBioBank Biobanking LIMS Software Product and Solutions
    • 2.9.4 TDBioBank Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 TDBioBank Recent Developments and Future Plans
  • 2.10 Autoscribe
    • 2.10.1 Autoscribe Details
    • 2.10.2 Autoscribe Major Business
    • 2.10.3 Autoscribe Biobanking LIMS Software Product and Solutions
    • 2.10.4 Autoscribe Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Autoscribe Recent Developments and Future Plans
  • 2.11 LabVantage
    • 2.11.1 LabVantage Details
    • 2.11.2 LabVantage Major Business
    • 2.11.3 LabVantage Biobanking LIMS Software Product and Solutions
    • 2.11.4 LabVantage Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 LabVantage Recent Developments and Future Plans
  • 2.12 Thermo Fisher Scientific
    • 2.12.1 Thermo Fisher Scientific Details
    • 2.12.2 Thermo Fisher Scientific Major Business
    • 2.12.3 Thermo Fisher Scientific Biobanking LIMS Software Product and Solutions
    • 2.12.4 Thermo Fisher Scientific Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.13 Ocimum Biosolutions
    • 2.13.1 Ocimum Biosolutions Details
    • 2.13.2 Ocimum Biosolutions Major Business
    • 2.13.3 Ocimum Biosolutions Biobanking LIMS Software Product and Solutions
    • 2.13.4 Ocimum Biosolutions Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Ocimum Biosolutions Recent Developments and Future Plans
  • 2.14 LabKey
    • 2.14.1 LabKey Details
    • 2.14.2 LabKey Major Business
    • 2.14.3 LabKey Biobanking LIMS Software Product and Solutions
    • 2.14.4 LabKey Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 LabKey Recent Developments and Future Plans
  • 2.15 Azenta US
    • 2.15.1 Azenta US Details
    • 2.15.2 Azenta US Major Business
    • 2.15.3 Azenta US Biobanking LIMS Software Product and Solutions
    • 2.15.4 Azenta US Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Azenta US Recent Developments and Future Plans
  • 2.16 Modul-Bio
    • 2.16.1 Modul-Bio Details
    • 2.16.2 Modul-Bio Major Business
    • 2.16.3 Modul-Bio Biobanking LIMS Software Product and Solutions
    • 2.16.4 Modul-Bio Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Modul-Bio Recent Developments and Future Plans
  • 2.17 LIMSABC
    • 2.17.1 LIMSABC Details
    • 2.17.2 LIMSABC Major Business
    • 2.17.3 LIMSABC Biobanking LIMS Software Product and Solutions
    • 2.17.4 LIMSABC Biobanking LIMS Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 LIMSABC Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biobanking LIMS Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biobanking LIMS Software by Company Revenue
    • 3.2.2 Top 3 Biobanking LIMS Software Players Market Share in 2025
    • 3.2.3 Top 6 Biobanking LIMS Software Players Market Share in 2025
  • 3.3 Biobanking LIMS Software Market: Overall Company Footprint Analysis
    • 3.3.1 Biobanking LIMS Software Market: Region Footprint
    • 3.3.2 Biobanking LIMS Software Market: Company Product Type Footprint
    • 3.3.3 Biobanking LIMS Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biobanking LIMS Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biobanking LIMS Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biobanking LIMS Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biobanking LIMS Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biobanking LIMS Software Consumption Value by Type (2021-2032)
  • 6.2 North America Biobanking LIMS Software Market Size by Application (2021-2032)
  • 6.3 North America Biobanking LIMS Software Market Size by Country
    • 6.3.1 North America Biobanking LIMS Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biobanking LIMS Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biobanking LIMS Software Consumption Value by Type (2021-2032)
  • 7.2 Europe Biobanking LIMS Software Consumption Value by Application (2021-2032)
  • 7.3 Europe Biobanking LIMS Software Market Size by Country
    • 7.3.1 Europe Biobanking LIMS Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 7.3.3 France Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biobanking LIMS Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biobanking LIMS Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biobanking LIMS Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biobanking LIMS Software Market Size by Region
    • 8.3.1 Asia-Pacific Biobanking LIMS Software Consumption Value by Region (2021-2032)
    • 8.3.2 China Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 8.3.5 India Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biobanking LIMS Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biobanking LIMS Software Consumption Value by Type (2021-2032)
  • 9.2 South America Biobanking LIMS Software Consumption Value by Application (2021-2032)
  • 9.3 South America Biobanking LIMS Software Market Size by Country
    • 9.3.1 South America Biobanking LIMS Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biobanking LIMS Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biobanking LIMS Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biobanking LIMS Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biobanking LIMS Software Market Size by Country
    • 10.3.1 Middle East & Africa Biobanking LIMS Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biobanking LIMS Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biobanking LIMS Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biobanking LIMS Software Market Drivers
  • 11.2 Biobanking LIMS Software Market Restraints
  • 11.3 Biobanking LIMS Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biobanking LIMS Software Industry Chain
  • 12.2 Biobanking LIMS Software Upstream Analysis
  • 12.3 Biobanking LIMS Software Midstream Analysis
  • 12.4 Biobanking LIMS Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biobanking LIMS Software market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Biobanking LIMS or biorepository LIMS, also known as biobanking sample management software, has several features, including: Sample management throughout the entire sample life cycle. Storage tracking to organize samples in a customizable and hierarchical storage pattern.
    This report is a detailed and comprehensive analysis for global Biobanking LIMS Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biobanking LIMS Software market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Biobanking LIMS Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Biobanking LIMS Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Biobanking LIMS Software market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biobanking LIMS Software
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biobanking LIMS Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cell&Co BioServices, RUCDR LIMS, Csols, Agilent Technologies, CloudLIMS, LabCollector, OpenSpecimen, BSI Systems, TDBioBank, Autoscribe, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Biobanking LIMS Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cloud Based
    On-Premise
    Market segment by Application
    Regenerative Medicine
    Life Science
    Clinical Research
    Market segment by players, this report covers
    Cell&Co BioServices
    RUCDR LIMS
    Csols
    Agilent Technologies
    CloudLIMS
    LabCollector
    OpenSpecimen
    BSI Systems
    TDBioBank
    Autoscribe
    LabVantage
    Thermo Fisher Scientific
    Ocimum Biosolutions
    LabKey
    Azenta US
    Modul-Bio
    LIMSABC
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Biobanking LIMS Software product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Biobanking LIMS Software, with revenue, gross margin, and global market share of Biobanking LIMS Software from 2021 to 2026.
    Chapter 3, the Biobanking LIMS Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biobanking LIMS Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Biobanking LIMS Software.
    Chapter 13, to describe Biobanking LIMS Software research findings and conclusion.

    Buy now